The study of ALM-488 for intra-operative visualization of nerves in head and neck surgery

Alume Biosciences, Inc is starting a new clinical trial of ALM-488 for Intra-Operative Visualization of Nerves in Head and Neck Surgery.

This protocol describes prospective, open-label, blinded, randomized controlled, multicenter pivotal studies to evaluate ALM-488.

The clinical trial started in April 29, 2022 and will continue throughout October 1, 2023.

Length Measurement will be primary outcome measure. Nerve Length Measurement will be compared between WLR and WLR with FL Overlay.

For more details:

Clinical Research News

Upcoming Clinical Trials